Top Stories: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), Netflix, Inc. (NASDAQ:NFLX), Bio-Rad Laboratories, Inc. (NYSE:BIO), Intel Corporation (NASDAQ:INTC),

On 25 February, Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) announced that the U.S. Food and Drug Association has granted orphan-drug designation to ZYN002 cannabidiol (CBD) gel, for the treatment of Fragile X syndrome (FXS). Fragile X syndrome is a genetic condition that causes intellectual disability, anxiety disorders, behavioral and learning challenges and various physical characteristics.

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) belongs to Healthcare sector. Its weekly performance is 6.29%. On last trading day company shares ended up at $6.42. Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) distance from 50-day simple moving average (SMA50) is 14.80%.

Netflix, Inc. (NASDAQ:NFLX) will debut My Beautiful Broken Brain, a documentary executive produced by Lynch On March 18. It follows Lotje’s Sodderland journey after experiencing a traumatic stroke in 2011 and having to learn to do things like write again

Netflix, Inc. (NASDAQ:NFLX) shares moved up 3.73% in last trading session and ended the day at $101.58. NFLX Gross Margin is 32.30% and its return on assets is 1.30%. Netflix, Inc. (NASDAQ:NFLX) quarterly performance is -21.21%.

Bio-Rad Laboratories, Inc. (NYSE:BIO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, MarketBeat.com reports.

On 04 March, Bio-Rad Laboratories, Inc. (NYSE:BIO) shares moved up 0.03% and was closed at $138.86. BIO EPS growth in last 5 year was -10.20%. Bio-Rad Laboratories, Inc. (NYSE:BIO) year to date (YTD) performance is 0.14%.

Intel Corporation (NASDAQ:INTC) has its own version of the tech, dubbed RealSense. which it is now apparently building into its own “HoloLens”-style augmented reality device.

Intel Corporation (NASDAQ:INTC) shares increased 0.16% in last trading session and ended the day at $30.63. INTC Gross Margin is 62.60% and its return on assets is 12.00%. Intel Corporation (NASDAQ:INTC) quarterly performance is -11.28%.

On 22 February, Nordson Corporation (NASDAQ:NDSN) reported results for the first quarter of fiscal year 2016. For the quarter ending January 31, 2016, sales were $372 million, a decrease of less than 2 percent from the prior year’s first quarter. This change in sales included a 4 percent increase in volume, comprised of slight growth in organic volume and 3 percent growth related to the first year effect of acquisitions.

Nordson Corporation (NASDAQ:NDSN) shares moved up 1.15% in last trading session and ended the day at $74.93. NDSN Gross Margin is 53.60% and its return on assets is 9.10%. Nordson Corporation (NASDAQ:NDSN) quarterly performance is 3.99%.

Leave a Reply

Your email address will not be published. Required fields are marked *